focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNLG.L Regulatory News (NLG)

  • There is currently no data for NLG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed NZSX & ASX listings

4 Jul 2016 09:00

RNS Number : 1095D
Arria NLG PLC
04 July 2016
 

4 July 2016

 

This announcement contains inside information

 

Arria NLG plc

("Arria NLG" or the "Company")

 

Proposed New Zealand Stock Exchange and Australian Stock Exchange listings

 

Arria NLG (AIM: NLG.L), a technology leader in Natural Language Generation ("NLG"), is pleased to provide an update on its proposed capital reorganisation which includes listings in New Zealand and Australia.

 

Introduction

 

Further to Arria's announcement on 10 June 2016, Arria is well advanced in preparing for the listing of the securities of a new holding company ("Arria NLG Group") on the main board of the New Zealand Stock Exchange (the "NZSX") and a secondary listing on the Australian Securities Exchange (the "ASX") (together the "Listings"). Once effected, the group's primary listing will shift from the London Stock Exchange AIM market ("AIM") to the New Zealand Stock Exchange.

 

To maintain the group's participation in the UK market, concurrent with the Listings, the Arria NLG Group will seek a listing of depository interests (representing shares and warrants) on the standard segment of the Main Market of the London Stock Exchange plc (the "Standard List") and at the same time the Company will seek the cancellation of the admission to trading on AIM of its existing ordinary shares (the "Existing Ordinary Shares") and existing quoted warrants (the "Quoted Warrants").

 

Arria believes this configuration of a primary listing to the NZSX together with secondary listings on the ASX and the Standard List, will better support Arria's global expansion plans.

 

Coinciding with the Listings, a fundraising will occur (the "Fundraising"). The Listings and the Fundraising will be subject to certain regulatory and other consents. 

 

Any new capital raised will be used to support Arria's commercial momentum by:

· continuing to add new clients and partners;

· developing Arria's SaaS products, (including a global launching of those products);

· continuing the development of Arria's core technologies; and

· an extension of the Group's existing Intellectual Property program by developing new patents and patent applications in the field of NLG.

The Board of Arria currently anticipate that full details of the Listings and the Fundraising will be announced in the current quarter.

 

Proposed capital reorganisation

 

In order to effect the Listings, it is the Company's current intention that Arria NLG Group (a newly incorporated company, registered in New Zealand) would acquire all of the Existing Ordinary Shares by means of a Scheme of Arrangement under sections 895 to 899 of the Companies Act 2006 (the "Scheme"). The structure of the Listings, Fundraising and the Scheme have been developed over recent months and it is anticipated that proposals will be put to holders of the various components of Arria's current capital structure (being the Existing Ordinary Shares, the Quoted Warrants, the existing loan notes and unlisted B warrants, and the employee options and LTIPs) as follows:

 

Existing Ordinary Shares

 

Under the Scheme, holders of Existing Ordinary Shares, as at the Scheme record date, would receive one share in Arria NLG Group (a "Arria NLG Group Share") for each Existing Ordinary Share held. Arria NLG Group Shares are expected to be listed on the NZSX and the ASX and depositary interests representing Arria NLG Group Shares are expected to be listed on the Standard List.

 

For every 10 Existing Ordinary Shares held in the Company, shareholders would also receive one warrant in Arria NLG Group (a "Bonus Warrant"). The exercise price of each Bonus Warrant will be NZ$1.00 (approximately £0.53) and the Bonus Warrants would expire on 15 February 2020. The Bonus Warrants are expected be listed on the NZSX and the ASX and depositary interests representing Bonus Warrants are expected to be listed on the Standard List.

 

Quoted Warrants

 

Holders of the Quoted Warrants will retain their Quoted Warrants but, outside of the Scheme, will be offered the opportunity to exercise prior to, and conditional upon, the Scheme becoming effective. However, the Company will seek cancellation of trading on AIM of the Quoted Warrants and the Company will not be seeking a listing of the current Quoted Warrants on the NZSX, the ASX, the Standard List or any other exchange. 

 

Amendments to the articles of association of the Company will be proposed at a general meeting to provide that any new ordinary shares in Arria NLG issued following the Scheme becoming effective will be subject to the Scheme. Consequently, upon the future exercise of a Quoted Warrant, the holders thereof will be issued with shares in Arria NLG which will then be immediately acquired by Arria NLG Group on the same terms as offered to the holders of the Existing Ordinary Shares. So, on exercise of every ten Quoted Warrants, the holders will receive ten shares in Arria NLG, which will then be immediately acquired by Arria NLG Group for ten new Arria NLG Group Shares and one Bonus Warrant. The expiry date of the Quoted Warrants is expected to be extended from 30 September 2017 to 15 March 2019.

 

B warrants

 

Holders of existing unlisted B warrants in the Company (the "B Warrants") will retain their B Warrants, but, as with the Quoted Warrants, will be outside of the Scheme. The proposed amendments to the articles of association of the Company will provide that any new ordinary shares in the Company issued following the Scheme becoming effective will be subject to the Scheme. Consequently, upon the future exercise of a B Warrant, the holders thereof will be issued with shares in the Company which will then be immediately acquired by Arria NLG Group on the same terms as offered to the holders of the Existing Ordinary shares, as set out above. The expiry date of the B Warrants will remain 11 June 2019 and will not be extended. Holders of B Warrants will also be offered the opportunity to exercise prior to, and conditional upon, the Scheme becoming effective.

 

Convertible loan notes

 

Holders of convertible loan notes in the Company (the "Loan Notes") will retain their Loan Notes. As with the Quoted Warrants and B Warrants, the Loan Notes will be outside of the Scheme and the proposed amendments to the articles of association of the Company will provide that any shares in the Company issued following the Scheme becoming effective will be subject to the Scheme. Consequently, upon a future conversion of the Loan Notes, the holders will be issued with shares in the Company which will then be immediately acquired by Arria NLG Group on the same terms as offered to the Existing Ordinary Shares. So, on conversion, holders of Loan Notes will receive ten shares in the Company for every £4.00 of Loan Notes (based on a current conversion price of 40p, and with fractional entitlements being rounded down), which are then immediately acquired by Arria NLG Group for ten new Arria NLG Group Shares and one Bonus Warrant. The expiry date of the Loan Notes will remain 31 October 2019 and will not be extended. Holders of Loan Notes will be asked to waive their rights to have their Loan Notes acquired and/or repaid upon the Scheme becoming effective. The Loan Notes will not be listed on any exchange.

 

Employee options and LTIPs

 

Appropriate proposals will be made to the holders of employee options and LTIPs at the same time as the Scheme being put to shareholders. 

 

Further details of the Scheme will be announced in due course. Should the Scheme become effective, then Arria NLG Group will become the new parent company of the Arria group and the existing parent company, Arria NLG, will become a wholly owned subsidiary of Arria NLG Group. Arria NLG would be re-registered as a private limited company. 

 

Proposed Arria NLG Group board members

 

It is proposed that on the listing of Arria NLG Group on the NZSX, Stuart Rogers, Chairman and Chief Executive of the Company, will become Non-Executive Chairman of Arria NLG Group, and Matthew Gould will become Chief Executive of Arria NLG Group. Wayne Thornhill will be appointed to the board of Arria NLG Group as Chief Financial Officer. Paul Kidney and Sharon Daniels (both non-executive directors of the Company) will become non-executive directors of Arria NLG Group and Barbara Kendall will be a non-executive director of Arria NLG Group.

 

Michael Higgins, a non-executive director of the Company, will step down from the Arria NLG board and will not be joining the board of Arria NLG Group. 

 

Proposed Fundraising

 

Arria NLG Group is currently seeking, conditional on the Listings taking place, to raise approximately £8.5 million of new capital through a public offer and subscription by way of the issue of new Arria NLG Group Shares. Pricing is subject to market evaluation and it is anticipated that the offer will consist of a bundle of securities incorporating ordinary shares in Arria NLG Group and listed warrants. The Board anticipates that the expected price of the offer of the securities bundle in the proposed fundraising, will be at a significant premium to the current Arria NLG ordinary share price.

 

It is the Company's intention that the Fundraising will be supported by a standby underwriting agreement between Arria NLG Group, the Company and MSL Capital Markets, which in turn will be supported by a series of standby sub-underwriting agreements with certain existing shareholders and new institutional investors. Further details of the proposed underwriting will be announced on completion of the underwriting agreements.

 

Commenting, Stuart Rogers, Chairman and Chief Executive of Arria NLG said: "Arria was founded as a UK company, and when the Company first listed in late 2013, it chose the UK's AIM market. Many of the Arria's founders and early investors are residents of New Zealand and Arria recognizes the strength of the equity markets in New Zealand and Australia with their focus on early stage software and technology companies. Further, during its first two years, Arria's staff were predominately based in the UK, whereas today, the core development staff are more evenly split between offices in the UK and Australia. With the ever-increasing media and marketplace focus on the Artificial Intelligence ("AI") category, and Arria's central place within this category which has been recognised in a number of recent technology media articles, Arria is confident that this strategic action of listing Arria NLG Group securities on both the NZSX and ASX exchanges, while maintaining a standard listing on the London Stock Exchange, will better provide the capital platform to support the group's global expansion plans within the AI category, and best serve the interests of the Company's shareholders."

 

For further information, please visit www.arria.com or contact:

Arria NLG plcStuart RogersChairman and Chief Executive

(and being the person making this notification for the purposes of the Market Abuse Regulations)

Tel +44 (0)20 7100 4540

Allenby Capital

Nominated Adviser & Joint BrokerNick NaylorJeremy PorterJames Reeve

Tel: +44 (0)20 3328 5656

MSL Capital MarketsLead ManagerAndrew McDouallJustine DunnettPeter Lynds

Tel: +64 (0)4 472 2716

Stockdale SecuritiesJoint BrokerAntonio BossiRobert Finlay

Tel: +44 (0)20 7601 6100

IFC AdvisoryFinancial PR and IRTim MetcalfeGraham HerringHeather Armstrong

Tel: +44 (0)20 3053 8671

tim.metcalfe@investor-focus.co.uk graham.herring@investor-focus.co.uk heather.armstrong@investor-focus.co.uk

Ruder FinnPR (USA)Scott Beaver (West Coast)Brianna Mulligan (East Coast) 

Tel: +1 541-326-5847Tel: +1 203-246-1304

Arria NLG

Arria NLG's core product is known as the Arria NLG Platform, a form of artificial intelligence software specialised in extracting information from complex data sources and communicating that information in natural language (i.e. as if written by a human). The scientific foundation for the Arria NLG Platform is based on more than 30 years of research and development by the founders of Arria Data2Text Limited at the University of Aberdeen. For additional information, visit www.arria.com. Follow Arria NLG on Twitter, LinkedIn, Google+ and YouTube.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSVBRNAABRRR
Date   Source Headline
19th Jan 20177:00 amRNSCompany update
6th Jan 201710:32 amRNSResult of General Meeting
19th Dec 20163:03 pmRNSRecount Product Launch UK
19th Dec 20167:00 amRNSProposed cancellation of trading on AIM
7th Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20168:45 amRNSTimetable and Progress to NZ and Australia IPO
21st Nov 20168:00 amRNSUpdate on Loan Note Subscriptions
7th Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20164:14 pmRNSUpdate on trading and proposed NZX listing
24th Oct 20167:00 amRNSFinancing update
13th Oct 20168:30 amRNSDirectorate Changes
5th Oct 20167:00 amRNSProduct Launch - Articulator Lite
3rd Oct 20167:00 amRNSFinancing update
13th Sep 20167:00 amRNSPartnership agreement with GeoCosmo Sciences SPC
5th Sep 20164:35 pmRNSPrice Monitoring Extension
31st Aug 20167:00 amRNSProduct Launch
8th Aug 20167:00 amRNSBoard Changes
18th Jul 20168:00 amRNSIssue of Loan Notes
12th Jul 20167:00 amRNSFurther pilot programmes secured
4th Jul 20169:00 amRNSProposed NZSX & ASX listings
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
16th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 20167:29 amRNSHalf Year Results
10th Jun 20167:00 amRNSListing and fundraising update
1st Jun 20167:00 amRNSImplementation and Licence Agreement
26th May 20167:00 amRNSGrant of 9th US Patent
16th May 20167:00 amRNSGrant of 8th US Patent
21st Mar 201610:37 amRNSPartnership Agreement with INOVX
18th Mar 20164:40 pmRNSSecond Price Monitoring Extn
18th Mar 20164:35 pmRNSPrice Monitoring Extension
18th Mar 20161:57 pmRNSFundraising Update
25th Feb 20161:00 pmRNSGrant of 7th US Patent
23rd Feb 20161:06 pmRNSHolding(s) in Company
18th Feb 20162:48 pmRNSDirectorate Change
12th Feb 20164:20 pmRNSHolding(s) in Company
12th Feb 20164:20 pmRNSHolding(s) in Company
11th Feb 20165:05 pmRNSHolding(s) in Company
3rd Feb 20167:00 amRNSGrant of 6th US Patent
29th Jan 20166:00 pmRNSTotal Voting Rights
28th Jan 201611:37 amRNSResult of AGM
25th Jan 20167:00 amRNSExercise of Options
11th Jan 20164:35 pmRNSPrice Monitoring Extension
11th Jan 20167:00 amRNSGrant of 5th US Patent
4th Jan 20167:00 amRNSFramework Agreement with Major US Utility Company
30th Dec 20157:00 amRNSGrant of Share Options
22nd Dec 20157:00 amRNSFramework Agreement with Genpact
11th Dec 20157:00 amRNSFinal Results for the year ended 30 September 2015
30th Nov 20155:40 pmRNSTotal Voting Rights
18th Nov 201511:54 amRNSUpdate on issue of convertible notes & warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.